US Stock Market Closed

Dashboard

PTC Therapeutics, Inc. (PTCT)

Current

- (-)

After Hours

Rating & Fair Value

Fair Value Premium lock
Institutional Holdings

H

Financial Strength

H

Sustainable Growth

S

Industry Comparison

H

Management & Equity

S

Analyst Opinion

B

Leverage & Liquidity

S

Fundamental Variables

H

Rating Performance

FV Performance

About

PTC Therapeutics, Inc. is a biopharmaceutical company, which engages in the discovery and commercialization of clinically-differentiated medicines. It focuses on the development of new treatments for multiple therapeutic areas, including rare diseases and oncology. The company was founded by Allan Steven Jacobson and Stuart W. Peltz on March 31, 1998 and is headquartered in South Plainfield, NJ.

CEO

Stuart W. Peltz

Employees

761

Industry

Neurology Biopharmaceuticals

Sector

Healthcare

Headquarters

South Plainfield

Exchange

NASDAQ

Summary Stats

Market Cap

2.86B

Revenue

569M

Net Income

-522M

EPS

-$7.38

Price-to-Earnings

-5.44

Price-to-Book

-31.59

Debt-to-Equity

-20.87

News

Analyst Ratings

Price targets projected by 12 analysts

High

$90.00

Average

$61.58

Low

$45.00

Ratings calculated by 13 analysts

Buy

7

Hold

6

Sell

0

Last Dividend

Amount

-

Dividend Date

-

Frequency

-

Dividend Yield

Earnings

Most Recent Earnings

Last Earnings for Q1 2022

Last Earnings

Missed by -$0.27

Actual

-$1.78 -17.9%

Consensus

-1.51

Report Date

Year Ago

-1.83

Year Ago Change %

Up 2%

Actual vs Estimates

XX

xxx

Upcoming Estimates Unavailable

Expected EPS
-

-

Actual EPS
-

--

Competitors

star Favorites